Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06042140 · ClinicalTrials.gov registry record · NA
Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair
A NA study of Myelomeningocele and Myeloschisis, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06042140: Recruiting NA study of Myelomeningocele and Myeloschisis, sponsored by The University of Texas Health Science Center, Houston.
NCT06042140 is a NA study of Myelomeningocele and Myeloschisis that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 100 participants, above the 66-participant average among 8 other Myelomeningocele trials with a reported enrollment target (52% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06042140, a NA study of Myelomeningocele and Myeloschisis, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective is to test the efficacy of a laparotomy-assisted fetoscopic surgical approach to cover spina bifida spinal cord developmental defects using cryopreserved human umbilical cords (NEOX Cord 1K®) as a meningeal and skin patch.
Conditions Studied
Interventions
- DEVICE NEOX Cord 1K applied fetoscopically
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-09-08 |
| Est. Completion | 2036-09-08 |
| Phase | NA |
What NCT06042140 shows while recruiting
NCT06042140 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 66-participant average among 8 other Myelomeningocele trials with a reported enrollment target (52% higher).
The record links to 3 conditions, with Myelomeningocele appearing as the primary indexed condition, and to 1 intervention - of which NEOX Cord 1K applied fetoscopically is the first listed.
NCT06042140 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06042140 about?
NCT06042140 is a clinical study titled "Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair". The objective is to test the efficacy of a laparotomy-assisted fetoscopic surgical approach to cover spina bifida spinal cord developmental defects using cryopreserved human umbilical cords (NEOX Cord 1K®) as a meningeal and skin patch.
What is the current status of trial NCT06042140?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-09-08. Estimated completion is 2036-09-08.
What conditions does trial NCT06042140 study?
This clinical trial studies the following conditions: Myelomeningocele, Myeloschisis, Spina Bifida; Fetus.
What interventions are being tested in trial NCT06042140?
The interventions under investigation include: NEOX Cord 1K applied fetoscopically (DEVICE).
Who is sponsoring clinical trial NCT06042140?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06042140 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myelomeningocele
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06042140's enrollment target sits among peer trials
100 3rd of 8 higher than 6 of 8 other Myelomeningocele trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myelomeningocele trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
RECRUITING · NA
-
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
RECRUITING · NA
-
In-Utero Endoscopic Correction of Spina Bifida
RECRUITING · NA
-
Fetoscopic NEOX Cord 1K® Spina Bifida Repair
ACTIVE NOT RECRUITING · NA
-
Fetoscopic Repair of Isolated Fetal Spina Bifida
ACTIVE NOT RECRUITING · NA
-
Incontinence and Quality of Life in Children With Spina Bifida
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI